Detalhe da pesquisa
1.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36029412
2.
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Oncologist
; 27(7): 534-e546, 2022 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35285484
3.
Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
Oncologist
; 27(3): 183-190, 2022 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35274713
4.
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Oncologist
; 27(4): 292-298, 2022 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35380713
5.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med
; 380(13): 1226-1234, 2019 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30917258
6.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30509771
7.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-25738668
8.
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
Breast Cancer Res Treat
; 172(3): 603-610, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30159789
9.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Br J Clin Pharmacol
; 81(6): 1134-41, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26859101
10.
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
Support Care Cancer
; 24(3): 1219-26, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26298334
11.
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
Support Care Cancer
; 24(3): 1339-47, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26329396
12.
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
Cancer
; 121(15): 2537-43, 2015 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25930719
13.
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Br J Haematol
; 168(6): 796-805, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25403830
14.
Combination anastrozole and fulvestrant in metastatic breast cancer.
N Engl J Med
; 367(5): 435-44, 2012 Aug 02.
Artigo
Inglês
| MEDLINE | ID: mdl-22853014
15.
A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
Am J Hematol
; 90(10): 877-81, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26149465
16.
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.
Oncologist
; 19(5): 492-7, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24710310
17.
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
Support Care Cancer
; 22(5): 1223-31, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24362907
18.
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
Support Care Cancer
; 21(4): 1185-92, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23150188
19.
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
Clin Breast Cancer
; 23(2): 155-161, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36566135
20.
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
J Natl Cancer Inst
; 115(11): 1302-1309, 2023 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37184928